Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats

Circulation

Volumn 98, Issue 19, 1998, Pages 2065-2073

  Iwanaga, Yoshitaka ^a   Kihara, Yasuki ^a   Hasegawa, Koji ^a   Inagaki, Koichi ^a   Yoneda, Takeshi ^a   Kaburagi, Satoshi ^a   Araki, Makoto ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Endothelin; Heart failure; Hypertension; Hypertrophy; Remodeling

Indexed keywords

BOSENTAN; DOXAZOSIN; ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE COURSE; DRUG MECHANISM; ENZYME IMMUNOASSAY; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART WEIGHT; HYPOKINESIA; MALE; MUSCLE LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0032506186     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.19.2065     Document Type: Article

References (42)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A noble potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Battistini B, Chailler P, Dorleans JP, Briere N, Sirosis P. Growth regulatory properties of endothelins. Peplides. 1993:14:385-399.
3. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett. 1988;238:249-252.
4. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 1991;69:209-215.
5. Haynes WO, Webb DJ. The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sei. 1993;84: 485-500.
6. Cody RJ, Hass GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992;85:504-507.
7. Shimoyama H, Sabbah HN, Borzak S, Tanimura M, Shevlyagin S, Scicli G, Goldstein S. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation. 1996;94: 779-784.
8. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet: 1995;346:732-736.
9. Ito H, Hiroe M. Hirata Y, Fujisaki H, Adachi S, Akimoto H, Ohta Y, Marumo F. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation. 1994;89: 2198-2203.
10. Kaddoura S, Firth JD, Boheler KR, Sugden PH, Poole-Wilson PA. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Circulation. 1996;93:2068-2079.
11. Sakai S, Miyauchi T, Kobayashi M, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 1996:384:353-355.
12. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl saltsensitive rats. Am J Physiol. 1994;267:H2471-H2482.
13. Inoko M, Kihara Y, Sasayama S. Neurohumoral factors during transition from left ventricular hypertrophy to failure in Dahl salt-sensitive rats. Biochem Biophys Res Commun. 1995;206:814-820.
14. Dahl LK, Heine MA, Tassinari L. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature. 1962:194:480-482.
15. Iwai J, Heine MA. Dahl salt-sensitive rats and human essential hypertension. J Hypertens. 1986;4(suppl):S29-S31.
16. Kitamura K, Tanaka J, Kalo T, Ogawa T, Eto T, Tanaka K. Immunoreactive endothelin in rat kidney inner medulla: marked decrease in spontaneously hypertensive rats. Biochem Biophys Res Commun. 1989:156: 1182-1186.
17. Suzuki N, Matsumoto H, Kitada C, Masaki T, Tsujino M. A sensitive sandwich-enzyme immunoassay for human endothelin. J Immunol Methods. 1989; 118:245-250.
18. Hasegawa K, Fujiwara H, Doyama K, Miyamae M, Fujiwara T, Suga S, Mukoyama M, Nakao K, Imura H, Sasayama S. Ventricular expression of brain natriuretic peptide in hypertrophie cardiomyopathy. Circulation. 1993:88:372-380.
19. Shioi T, Matumori A, Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation. 1996;94: 2930-2937.
20. Nadeau KC, Azuma H, Tilney NL. Sequential cytokine dynamics in chronic rejection of rat renal allograft: roles for cytokines RANTES and MCP-1. ProcNail Acad Sci USA. 1995;92:8729-8733.
21. Wang X, Douglas SA, Louden C, Vickery-Clark LM, Feuerstein GZ, Ohlstein EH. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-I, and endothelin-A and endolhelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Cire Res. 1996:78:322-328.
22. Fort P, Marty L, Piechaczyk M, el Sabrouty S, Dani C, Jeanteuer P, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985:13:1431-1442.
23. Clozel M, Breu V, Gray GA, Kaiina B, Löffler BM, Bum K, Cassai JM, Hirth G, Müller M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Phannacol Exp Ther. 1994:270:228-235.
24. Mulder M, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F, Compagnon P, Mace B, Comoy E, Letac B, Thuillez C. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation. 1997;96:1976-1982.
25. Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972;45:602-611.
26. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. CircRes. 1979:44:503-512.
27. Ito H, Hirata Y, Adachi M, Tanaka M, Tsujino A, Koike A, Nogami F, Marumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993;92:398-403.
28. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Kurihara H, Aikawa R, Tanaka H, Yazaki Y. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 1996:271:3221-3228.
29. Thibault G, Arguin C, Garcia R. Cardiac endothelin-1 content and receptor subtype in spontaneously hypertensive rats. J Mol Cell Cardiol. 1995:27:2327-2336.
30. Li JS, Schiffrin L. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension. 1995:25:495-500.
31. Hiroe M, Hirata Y, Fujita N, Umezawa S, Ito H, Tsujino M, Koike A, Nogami A, Takamoto T, Marumo F. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am Mean J. 1991;68:1114-1115.
32. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards \VD, Burnett JC Jr. Endothelin in human congestive heart failure. Circulation. 1994;89:1580-1586.
33. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Circulation. 1995;91:2642-2654.
34. Teerlink JR, Löffler BM, Hess P, Maire JP, Clozel M, Clozel JP. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Circulation. 1994;90:2510-2518.
35. A receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation. 1996;94:2131-2137.
36. Kihara Y, Murakami T, Tomita T, Inoko M, Sasayama S. Transition to overt heart failure in Dahl salt-sensitive rats is preceded by G-protein-mediated β-adrenergic desensitization. Pathophysiology. 1994; l(SuppI):306. Abstract.
37. Kelly RA, Eid H, Krämer BK, O'Neill M, Liang BT, Reers M, Smith TW. Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway. J Clin Invest. 1990;86:1164-1171.
38. Ono K, Tsujimoto G, Sakamoto A, Eto K, Masaki T, Ozaki Y, Satake M. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature. 1994:370:301-304.
39. Jones LG. Inhibition of cyclic AMP accumulation by endothelin is pertussis toxin sensitive and calcium independent in isolated adult feline cardiac myocytes. Life Sci. 1996;58:115-123.
40. 2+ ATPase gene expression and calcium reuptake. J Mol Cell Cardiol. 1996;28:2467-2477.
41. Prasad MR. Endothelin stimulates degradation of phospholipids in isolated rat hearts. Biochem Biophys Res Commun. 1991:174:952-957.
42. Kihara Y, Inoko M, Sasayama S. Changes of myocardial contractile state and the intracellular calcium transients during transitions to heart failure: studies in Dahl rat heart failure model. J Cardiac Failure. 1996;2: S113-S120.